TNBIOTCGrain Mill ProductsFiscal year ends December 31
Tanke Biosciences Corp
Financials through Q3 FY2013, quarter ended Sep 30, 2013Last filing: 10-Q on Nov 14, 2013
$0.03+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $399.72K
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.0200 (−40.00%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Tanke Biosciences Corp saw revenue fall 19.5% to $22.96M over the twelve months to Sep 30, 2013. Operating income fell 101.1% to -$57.27K, moving the operating margin from 18.2% to -0.2%. Free cash flow was -$6.13M, down 273.3% from a year earlier.
Revenue
$22.96M
-19.5% vs. a year earlier
Operating income
-$57.27K
-101.1% vs. a year earlier
Free cash flow
-$6.13M
-273.3% vs. a year earlier
EPS, diluted
-$0.12
-163.2% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2013
Valuation
- Market cap
- $399.72K
- P/E ratio
- –
- Price to sales
- 0.02
- Price to book
- 0.03
- Dividend yield
- –
- Free cash flow yield
- -1532.72%
Fundamentals
- Revenue
- $22.96M
- Net income
- -$1.64M
- EPS, diluted
- -$0.12
- Free cash flow
- -$6.13M
- Book value per share
- $1.17
- Diluted shares
- 13M
Four years at a glance
Fiscal years 2009 to 2012 and trailing twelve months, USD
Revenue
$22.96M-19.5% YoY
Gross profit
$7.41M-26.2% YoY
Operating income
-$57.27K-101.1% YoY
Net income
-$1.64M-164.1% YoY
EPS, diluted
-$0.12-163.2% YoY
Free cash flow
-$6.13M-273.3% YoY
Reported periodTrailing twelve months